Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

CVS Caremark said in May that the move will save its employer clients 10 to 15% when compared to the previous year, the newspaper reported. Some employers won’t pay for either treatment because ...

PBMs also process pharmacy claims. The largest are CVS Caremark; Express Scripts, which is Cigna’s PBM; and OptiumRx, which is UnitedHealth. The three companies control about 80% of the market.

CVS Health Corporation’s share was trading at $67.58 as of June 24th. CVS’s trailing and forward P/E ratios were 16.13 and 11.49, respectively, according to Yahoo Finance.

Wegovy will now be the GLP-1 weight loss drug of choice under plans that are managed by CVS Caremark. If they stay on Zepbound for their GLP-1 weight loss treatment, they will have to pay full price, ...